Holen Sie sich die Stockscreener-App
1.16
0.87%
0.01
Vorhandelsmarkt:
1.25
0.09
+7.76%
Schlusskurs vom Vortag:
$1.15
Offen:
$1.18
24-Stunden-Volumen:
157.88K
Relative Volume:
0.07
Marktkapitalisierung:
$72.83M
Einnahmen:
$11.03M
Nettoeinkommen (Verlust:
$-44.24M
KGV:
-1.871
EPS:
-0.62
Netto-Cashflow:
$-42.61M
1W Leistung:
+12.62%
1M Leistung:
+48.91%
6M Leistung:
-28.40%
1J Leistung:
+5.45%
1-Tages-Spanne:
$1.13
$1.18
1-Wochen-Bereich:
$1.02
$1.27
52-Wochen-Spanne:
$0.5327
$1.90
Hyperfine Inc Stock (HYPR) Company Profile
Firmenname
Hyperfine Inc
Sektor
Branche
Telefon
866-796-6767
Adresse
351 NEW WHITFIELD STREET, GUILFORD
Vergleichen Sie HYPR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
1.16 | 91.07M | 11.03M | -44.24M | -42.61M | -0.62 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-08-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-05-31 | Eingeleitet | Evercore ISI | Outperform |
| 2022-04-14 | Eingeleitet | Wells Fargo | Overweight |
Hyperfine Inc Aktie (HYPR) Neueste Nachrichten
Is Hyperfine Inc. stock a top performer YTDDaily Return Maximizer Alerts - thegnnews.com
Hyperfine - Hartford Business Journal
Guilford-based Hyperfine Inc. regains compliance for Nasdaq stock listing - Hartford Business Journal
What makes Hyperfine Inc. stock price move sharplyCapital Efficiency Optimized Stock Alerts Reviewed - beatles.ru
Hyperfine Reaches Nasdaq Compliance with Improved Bid Price - AInvest
Hyperfine Regains Nasdaq Compliance with Bid Price - TipRanks
Hyperfine Initiates Sales of Next-Gen Swoop System With Optive AI Software - Medical Product Outsourcing
Is Hyperfine Inc. stock a growth or value playTechnical Stock Breakout Predictions Signal Entry Points - beatles.ru
Hyperfine Exceeds Enrollment Expectations with 100 Patients in NEURO PMR Study - AInvest
Iac Inc. shares rise 1.24% intraday after Hyperfine Inc. achieves clinical milestone. - AInvest
Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-Generation Swoop® System - Nasdaq
How volatile is Hyperfine Inc. stock compared to the marketAchieve rapid wealth accumulation through smart investing - Jammu Links News
What catalysts could drive Hyperfine Inc. stock higher in 2025Superior portfolio returns - Jammu Links News
Is Hyperfine Inc. a growth stock or a value stockMaximize returns with disciplined trading - Jammu Links News
Hyperfine Enrolls First Patients in PRIME Study to Accelerate AI-Powered Portable MRI in Emergency Departments - AInvest
Is it the right time to buy Hyperfine Inc. stockFree Predictions - Jammu Links News
What is the risk reward ratio of investing in Hyperfine Inc. stockPhenomenal wealth increase - Jammu Links News
Hyperfine Launches PRIME Study To Evaluate AI-Powered Portable MRI In Emergency Department Triage - 富途牛牛
Hyperfine launches study to evaluate portable AI-powered MRI in emergency care - Medical Economics
What institutional investors are buying Hyperfine Inc. stockReal Time Planner For Fast Growth - Jammu Links News
What is the dividend policy of Hyperfine Inc. stockPost Market Growth Plan To Watch Now - jammulinksnews.com
Hyperfine Begins Study of AI-Powered Portable MRI in Emergency Departments - Medical Product Outsourcing
CANADIAN UTILITIES REPORTS SECOND QUARTER 2025 EARNINGS - The Globe and Mail
Hyperfine Enrolls First Patients in PRIME Study to Accelerate Adoption of AI-Powered Portable MRI in Emergency Departments. - AInvest
Hyperfine Announces First Patients Enrolled in PRIME Study Aimed at Accelerating Adoption of AI-Powered Portable MRI in Emergency Departments - The Globe and Mail
Ares Capital Reports Strong Q2 2025 Earnings - The Globe and Mail
Hyperfine, Inc. to Announce Second Quarter 2025 Financial Results on August 13, 2025 - Business Wire
Hyperfine, Inc. shares rise 1.82% after-hours after promising early results from Alzheimer’s study. - AInvest
Hyperfine stock rises after promising Alzheimer’s monitoring results - Investing.com
Hyperfine stock rises after promising Alzheimer’s monitoring results By Investing.com - Investing.com South Africa
Hyperfine Swoop® AI-Powered Portable MRI System Demonstrates 100% Sensitivity for ARIA-E Detection in New Data Presented at the 2025 Alzheimer’s Association International Conference - 01net
How strong is Hyperfine Inc. company’s balance sheetUnmatched market gains - jammulinksnews.com
Is Hyperfine Inc. stock overvalued or undervaluedExplosive earnings growth - Jammu Links News
What analysts say about Hyperfine Inc. stockUnprecedented profit potential - PrintWeekIndia
Finanzdaten der Hyperfine Inc-Aktie (HYPR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):